Lyme Arthritis: 3 Things to Know
What’s new: advances in serodiagnostic testing, role of T cell activation in Lyme arthritis, and post-treatment Lyme disease syndrome.
References1. Branda JA, Body BA, Boyle J, et al. Advances in serodiagnostic testing for Lyme disease are at hand. Clin Infect Dis. 2018;66:1133-1139. doi: 10.1093/cid/cix943.2. Whiteside SK, Snook JP, Ma Y, et al. IL-10 deficiency reveals a role for TLR2-dependent bystander activation of T cells in Lyme arthritis. J Immunol. 2018;200:1457-1470. doi: 10.4049/jimmunol.1701248.3. Rebman AW, Bechtold KT, Yang T, et al. The clinical, symptom, and quality-of-life characterization of a well-defined group of patients with posttreatment Lyme disease syndrome. Front Med (Lausanne). 2017;4:224. doi: 10.3389/fmed.2017.00224.
